ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
Clinical trials for ADVANCED HEPATOCELLULAR CARCINOMA (HCC) explained in plain language.
Never miss a new study
Get alerted when new ADVANCED HEPATOCELLULAR CARCINOMA (HCC) trials appear
Sign up with your email to follow new studies for ADVANCED HEPATOCELLULAR CARCINOMA (HCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Tracking survival in advanced liver cancer patients on new immune drugs
Disease control Not yet recruitingThis study aims to track how well patients with advanced liver cancer do while receiving immune checkpoint inhibitor drugs as part of their regular treatment. Researchers will follow 75 patients to measure how long they live and how long the cancer stays controlled, while also mo…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
Sponsor: Ahmed Karam Helmy • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Targeted attack on liver cancer: new trial tests direct drug delivery
Disease control Not yet recruitingThis trial is testing a new way to deliver chemotherapy directly to liver tumors in people with advanced liver cancer that has worsened after first treatment. Doctors will thread a catheter through an artery to infuse a special form of the drug paclitaxel directly into the liver,…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
Phase: PHASE1, PHASE2 • Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC